Literature DB >> 18421487

Molecular characterisation of linezolid resistance in two vancomycin-resistant (VanB) Enterococcus faecium isolates using Pyrosequencing.

B Saager1, H Rohde, B S Timmerbeil, G Franke, W Pothmann, J Dahlke, S Scherpe, I Sobottka, P Heisig, M A Horstkotte.   

Abstract

In this paper, we describe the phenotypic and molecular characteristics of two clinically relevant, vancomycin-resistant (VanB), linezolid-resistant Enterococcus faecium isolates. Pyrosequencing showed the G to T single nucleotide polymorphism at bp 2576 in the genes coding for 23S rRNA and was used to quantify the proportion of G to T mutations among six different 23S rRNA genes in E. faecium as a marker for the molecular level of resistance to linezolid. In both isolates, the G to T mutation was found in two of six alleles, and no further mutations in the genes coding for 23S rRNA were found. The dynamic process of linezolid resistance could be demonstrated by the complete reversion of resistant alleles back to only wild type alleles in consecutive isolates of one isolate. Pyrosequencing being used to detect and quantify resistance to linezolid has been proven as a fast and reliable molecular screening method for monitoring linezolid resistance.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18421487     DOI: 10.1007/s10096-008-0514-6

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  12 in total

1.  Simple and reliable multiplex PCR assay for surveillance isolates of vancomycin-resistant enterococci.

Authors:  R Kariyama; R Mitsuhata; J W Chow; D B Clewell; H Kumon
Journal:  J Clin Microbiol       Date:  2000-08       Impact factor: 5.948

2.  Detection of oxazolidinone-resistant Enterococcus faecalis and Enterococcus faecium strains by real-time PCR and PCR-restriction fragment length polymorphism analysis.

Authors:  Neil Woodford; Luke Tysall; Cressida Auckland; Mark W Stockdale; Andrew J Lawson; Rachel A Walker; David M Livermore
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

3.  Rapid detection and estimation by pyrosequencing of 23S rRNA genes with a single nucleotide polymorphism conferring linezolid resistance in Enterococci.

Authors:  Alistair Sinclair; Catherine Arnold; Neil Woodford
Journal:  Antimicrob Agents Chemother       Date:  2003-11       Impact factor: 5.191

4.  Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR.

Authors:  S Dutka-Malen; S Evers; P Courvalin
Journal:  J Clin Microbiol       Date:  1995-01       Impact factor: 5.948

5.  Nosocomial outbreak of vancomycin-resistant Enterococcus faecium at a German university pediatric hospital.

Authors:  H A Elsner; I Sobottka; H H Feucht; E Harps; C Haun; D Mack; R Ganschow; R Laufs; P M Kaulfers
Journal:  Int J Hyg Environ Health       Date:  2000-10       Impact factor: 5.840

6.  Resistance to linezolid: characterization of mutations in rRNA and comparison of their occurrences in vancomycin-resistant enterococci.

Authors:  J Prystowsky; F Siddiqui; J Chosay; D L Shinabarger; J Millichap; L R Peterson; G A Noskin
Journal:  Antimicrob Agents Chemother       Date:  2001-07       Impact factor: 5.191

7.  Varying linezolid susceptibility of vancomycin-resistant Enterococcus faecium isolates during therapy: a case report.

Authors:  Stefanie Swoboda; Stefan Fritz; Marcus E Martignoni; Rita A Feldhues; Torsten Hoppe-Tichy; Markus W Buchler; Heinrich K Geiss
Journal:  J Antimicrob Chemother       Date:  2005-09-05       Impact factor: 5.790

8.  Mechanism of action of oxazolidinones: effects of linezolid and eperezolid on translation reactions.

Authors:  D L Shinabarger; K R Marotti; R W Murray; A H Lin; E P Melchior; S M Swaney; D S Dunyak; W F Demyan; J M Buysse
Journal:  Antimicrob Agents Chemother       Date:  1997-10       Impact factor: 5.191

9.  Surveillance of linezolid resistance in Germany, 2001-2002.

Authors:  J Brauers; M Kresken; D Hafner; P M Shah
Journal:  Clin Microbiol Infect       Date:  2005-01       Impact factor: 8.067

10.  Response to emerging infection leading to outbreak of linezolid-resistant enterococci.

Authors:  Marion A Kainer; Rose A Devasia; Timothy F Jones; Bryan P Simmons; Kelley Melton; Susan Chow; Joyce Broyles; Kelly L Moore; Allen S Craig; William Schaffner
Journal:  Emerg Infect Dis       Date:  2007-07       Impact factor: 6.883

View more
  5 in total

1.  Compensation of fitness costs and reversibility of antibiotic resistance mutations.

Authors:  Pia Schulz zur Wiesch; Jan Engelstädter; Sebastian Bonhoeffer
Journal:  Antimicrob Agents Chemother       Date:  2010-02-22       Impact factor: 5.191

2.  An evolved oxazolidinone with selective potency against Mycobacterium tuberculosis and gram positive bacteria.

Authors:  Amit Kaushik; Abigail M Heuer; Drew T Bell; Jeffrey C Culhane; David C Ebner; Nicole Parrish; J Thomas Ippoliti; Gyanu Lamichhane
Journal:  Bioorg Med Chem Lett       Date:  2016-06-09       Impact factor: 2.823

3.  Molecular analysis of linezolid resistance in clinical Enterococcus faecium isolates by polymerase chain reaction and pyrosequencing.

Authors:  P Schnitzler; K Schulz; C Lampson; M Geiss; H K Geiss
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-09-03       Impact factor: 3.267

4.  Tedizolid susceptibility in linezolid- and vancomycin-resistant Enterococcus faecium isolates.

Authors:  E-M Klupp; A Both; C Belmar Campos; H Büttner; C König; M Christopeit; M Christner; M Aepfelbacher; H Rohde
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-08-15       Impact factor: 3.267

5.  Linezolid-resistant Enterococcus faecium strains isolated from one hospital in Poland -commensals or hospital-adapted pathogens?

Authors:  Beata Krawczyk; Magdalena Wysocka; Roman Kotłowski; Marek Bronk; Michał Michalik; Alfred Samet
Journal:  PLoS One       Date:  2020-05-26       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.